HK1010730A1 - 4_amino-n-(4-methyl -4- piperidinyl)-2- methoxybenzamides their preparation and their use as 5-ht2 antagonists - Google Patents

4_amino-n-(4-methyl -4- piperidinyl)-2- methoxybenzamides their preparation and their use as 5-ht2 antagonists

Info

Publication number
HK1010730A1
HK1010730A1 HK98111599A HK98111599A HK1010730A1 HK 1010730 A1 HK1010730 A1 HK 1010730A1 HK 98111599 A HK98111599 A HK 98111599A HK 98111599 A HK98111599 A HK 98111599A HK 1010730 A1 HK1010730 A1 HK 1010730A1
Authority
HK
Hong Kong
Prior art keywords
pct
compounds
halo
hydrogen
formula
Prior art date
Application number
HK98111599A
Other languages
English (en)
Inventor
Josepha Eduarda Maria Francisca Leysen
Daele Georges Henri Paul Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1010730A1 publication Critical patent/HK1010730A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK98111599A 1992-07-17 1998-10-29 4_amino-n-(4-methyl -4- piperidinyl)-2- methoxybenzamides their preparation and their use as 5-ht2 antagonists HK1010730A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91430692A 1992-07-17 1992-07-17
PCT/EP1993/001993 WO1994002462A1 (en) 1992-07-17 1993-07-08 4-amino-n^_-(4-methyl-4-piperidinyl)-2-methoxybenzamides

Publications (1)

Publication Number Publication Date
HK1010730A1 true HK1010730A1 (en) 1999-06-25

Family

ID=25434170

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98111599A HK1010730A1 (en) 1992-07-17 1998-10-29 4_amino-n-(4-methyl -4- piperidinyl)-2- methoxybenzamides their preparation and their use as 5-ht2 antagonists

Country Status (17)

Country Link
US (3) US5498618A (ko)
EP (1) EP0650475B1 (ko)
JP (1) JP3257677B2 (ko)
KR (1) KR100243535B1 (ko)
AT (1) ATE184001T1 (ko)
AU (1) AU668208B2 (ko)
CA (1) CA2138150C (ko)
DE (1) DE69326245T2 (ko)
DK (1) DK0650475T3 (ko)
ES (1) ES2137996T3 (ko)
FI (1) FI109997B (ko)
GR (1) GR3031820T3 (ko)
HK (1) HK1010730A1 (ko)
HU (1) HUT71886A (ko)
IL (1) IL106356A (ko)
NO (1) NO303011B1 (ko)
WO (1) WO1994002462A1 (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9319534D0 (en) * 1993-09-22 1993-11-10 Boots Co Plc Therapeutic agents
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5919934A (en) * 1997-02-19 1999-07-06 The George Washington University Compounds, compositions, and methods for cancer imaging and therapy
AU5569800A (en) * 1999-06-30 2001-01-31 Santen Pharmaceutical Co. Ltd. Brain sigma-1 receptor-binding ligand
KR20010017625A (ko) * 1999-08-12 2001-03-05 윤재승 시사프라이드의 제조 방법
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
ITRM20050390A1 (it) * 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
EP3233799B1 (en) 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamine d2 receptor ligands
EP3233077A4 (en) * 2014-12-19 2018-08-08 The Broad Institute Inc. Dopamine d2 receptor ligands
CN110950843B (zh) * 2019-11-28 2022-12-27 广东东阳光药业有限公司 取代的苯酰胺衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1507462A (en) * 1974-03-21 1978-04-12 Gallardo Antonio Sa N-heterocyclic substituted benzamides methods for their preparation and compositions containing them
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US4962115A (en) * 1981-10-01 1990-10-09 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
GB8718346D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa Substituted benzamides

Also Published As

Publication number Publication date
DE69326245D1 (de) 1999-10-07
WO1994002462A1 (en) 1994-02-03
JP3257677B2 (ja) 2002-02-18
CA2138150C (en) 2005-04-19
ATE184001T1 (de) 1999-09-15
US5498618A (en) 1996-03-12
KR100243535B1 (ko) 2000-03-02
FI950180A0 (fi) 1995-01-16
AU668208B2 (en) 1996-04-26
CA2138150A1 (en) 1994-02-03
JPH07509234A (ja) 1995-10-12
IL106356A0 (en) 1993-11-15
KR950702183A (ko) 1995-06-19
ES2137996T3 (es) 2000-01-01
HUT71886A (en) 1996-02-28
FI109997B (fi) 2002-11-15
AU4702993A (en) 1994-02-14
EP0650475B1 (en) 1999-09-01
US5691358A (en) 1997-11-25
US5688814A (en) 1997-11-18
IL106356A (en) 1997-06-10
DK0650475T3 (da) 2000-03-20
NO950136D0 (no) 1995-01-13
GR3031820T3 (en) 2000-02-29
DE69326245T2 (de) 2000-05-18
FI950180A (fi) 1995-01-16
HU9500138D0 (en) 1995-03-28
NO950136L (no) 1995-02-03
NO303011B1 (no) 1998-05-18
EP0650475A1 (en) 1995-05-03

Similar Documents

Publication Publication Date Title
CZ208895A3 (en) Novel imidazopyridine compounds, process for preparing such compounds and their salts, the use of said compounds and salts in the preparation of medicaments and a medicament containing thereof
PT98064A (pt) Processo para a preparacao de novos compostos anti-epilepticos, nomeadamente acidos aminoalcanofosfinicos n-substituidos
MX9305379A (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene.
ZA935276B (en) 3-(hydroxybenzylidenyl)-indolin-2-ones processes for their preparation and pharmaceutical compositions containing them
HUT73977A (en) Vasoconstrictive substituted aryloxyalkyl diamines, process for producing them, and pharmaceutical compositions containing them
MY117852A (en) Alkylaminobenzothiazole and- benzoxazole derivatives
HK1010730A1 (en) 4_amino-n-(4-methyl -4- piperidinyl)-2- methoxybenzamides their preparation and their use as 5-ht2 antagonists
ES8207124A1 (es) Un procedimiento para la preparacion de derivados de aminas secundarias.
GR3023934T3 (en) New naphthalene amides and sulfonamides, process for their preparation and pharmaceutical compositions containing them
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
ES8404852A1 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
ES8103049A1 (es) Un procedimiento de preparacion de nuevas fenoxiaminas hete-rociclicas
ES8607314A1 (es) Tetrahidrotienopiridinas
ES2000907A6 (es) Procedimiento de preparar compuestos 2-oxaisocefen microbiologicamente activos
TW261605B (ko)
ES8401946A1 (es) Procedimiento para la preparacion de sulfonilureas.
ES8306117A1 (es) "procedimiento para la preparacion de una sulfonilurea".
ES8307778A1 (es) Procedimiento para preparar difenilbutil-1-piperazinocarboxilatos.
HUT73679A (en) N-{[1-[4-(4-fluorophenoxy)butyl]-4-piperidinyl]-n-methylamino}-2-benzothiazolol derivatives class iii. antiarhythmic agents containing the same and process for their preparation
ES8605819A1 (es) Procedimiento de preparacion de nuevos derivados nucleosidos.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080708